167 related articles for article (PubMed ID: 37395342)
1. The epigenetic modifier lysine methyltransferase 2C is frequently mutated in gastric remnant carcinoma.
Sun B; Chen H; Lao J; Tan C; Zhang Y; Shao Z; Xu D
J Pathol Clin Res; 2023 Sep; 9(5):409-422. PubMed ID: 37395342
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus genome polymorphisms of Epstein-Barr virus-associated gastric carcinoma in gastric remnant carcinoma in Guangzhou, southern China, an endemic area of nasopharyngeal carcinoma.
Chen JN; Jiang Y; Li HG; Ding YG; Fan XJ; Xiao L; Han J; Du H; Shao CK
Virus Res; 2011 Sep; 160(1-2):191-9. PubMed ID: 21723347
[TBL] [Abstract][Full Text] [Related]
3. Carcinogenesis in the remnant stomach following distal gastrectomy with billroth II reconstruction is associated with high-level microsatellite instability.
Aya M; Yashiro M; Nishioka N; Onoda N; Hirakawa K
Anticancer Res; 2006; 26(2B):1403-11. PubMed ID: 16619551
[TBL] [Abstract][Full Text] [Related]
4.
Cho SJ; Yoon C; Lee JH; Chang KK; Lin JX; Kim YH; Kook MC; Aksoy BA; Park DJ; Ashktorab H; Smoot DT; Schultz N; Yoon SS
Clin Cancer Res; 2018 Dec; 24(24):6556-6569. PubMed ID: 30108106
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and minimally invasive treatment of gastric remnant cancer].
Wu AW; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Feb; 16(2):132-4. PubMed ID: 23446471
[TBL] [Abstract][Full Text] [Related]
6. Microsatellite instability and Epstein-Barr virus infection in gastric remnant cancers.
Chang MS; Lee JH; Kim JP; Kim HS; Lee HS; Kim CW; Kim YI; Kim WH
Pathol Int; 2000 Jun; 50(6):486-92. PubMed ID: 10886725
[TBL] [Abstract][Full Text] [Related]
7. Surgery for Gastric Remnant Cancer Results in Similar Overall Survival Rates Compared with Primary Gastric Cancer: A Propensity Score-Matched Analysis.
Galata C; Ronellenfitsch U; Weiß C; Blank S; Reißfelder C; Hardt J
Ann Surg Oncol; 2020 Oct; 27(11):4196-4203. PubMed ID: 32488518
[TBL] [Abstract][Full Text] [Related]
8. Distinct mutational profile and immune microenvironment in microsatellite-unstable and
Hwang HS; Kim D; Choi J
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34607897
[TBL] [Abstract][Full Text] [Related]
9. Gastric remnant cancer and long-term survival in Central Norway 2001 to 2016 - A population-based study.
Ubøe AAS; Våge C; Mjønes P; Bringeland EA; Fossmark R
Surg Oncol; 2023 Dec; 51():102008. PubMed ID: 37866308
[TBL] [Abstract][Full Text] [Related]
10. Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair.
Ratovomanana T; Cohen R; Svrcek M; Renaud F; Cervera P; Siret A; Letourneur Q; Buhard O; Bourgoin P; Guillerm E; Dorard C; Nicolle R; Ayadi M; Touat M; Bielle F; Sanson M; Le Rouzic P; Buisine MP; Piessen G; Collura A; Fléjou JF; de Reyniès A; Coulet F; Ghiringhelli F; André T; Jonchère V; Duval A
Gastroenterology; 2021 Sep; 161(3):814-826.e7. PubMed ID: 33992635
[TBL] [Abstract][Full Text] [Related]
11. Mutations of PI3K-AKT-mTOR pathway as predictors for immune cell infiltration and immunotherapy efficacy in dMMR/MSI-H gastric adenocarcinoma.
Wang Z; Wang X; Xu Y; Li J; Zhang X; Peng Z; Hu Y; Zhao X; Dong K; Zhang B; Gao C; Zhao X; Chen H; Cai J; Bai Y; Sun Y; Shen L
BMC Med; 2022 Apr; 20(1):133. PubMed ID: 35443723
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic differences between gastric remnant cancer and primary cancer in the upper third of the stomach.
Imada T; Rino Y; Takahashi M; Shiozawa M; Hatori S; Noguchi Y; Amano T; Kobayashi O; Sairenji M; Motohashi H
Anticancer Res; 1998; 18(1A):231-5. PubMed ID: 9568082
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-associated gastric carcinoma in the remnant stomach: de novo and metachronous gastric remnant carcinoma.
Kaizaki Y; Hosokawa O; Sakurai S; Fukayama M
J Gastroenterol; 2005 Jun; 40(6):570-7. PubMed ID: 16007390
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and characteristics of gastric remnant cancer: A systematic review and meta-analysis.
Mak TK; Guan B; Peng J; Chong TH; Wang C; Huang S; Yang J
Asian J Surg; 2021 Jan; 44(1):11-17. PubMed ID: 32253109
[TBL] [Abstract][Full Text] [Related]
15. Is annual endoscopic surveillance necessary for the early detection of gastric remnant cancer in Korea? A retrospective multi-center study.
Jang HJ; Choi MH; Shin WG; Kim KH; Baek IH; Kim KO; Park CH; Kim JB; Baik KH; Kae SH; Kim HY
Hepatogastroenterology; 2014; 61(133):1283-6. PubMed ID: 25436297
[TBL] [Abstract][Full Text] [Related]
16. Gastric Remnant Cancer: Continuing Serious and Insidious Problem for Surgeons.
Oymaci E; Sari E; Uçar AD; Erkan N; Yildirim M
Hepatogastroenterology; 2015 May; 62(139):727-31. PubMed ID: 26897962
[TBL] [Abstract][Full Text] [Related]
17. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.
Wang R; Song S; Harada K; Ghazanfari Amlashi F; Badgwell B; Pizzi MP; Xu Y; Zhao W; Dong X; Jin J; Wang Y; Scott A; Ma L; Huo L; Vicente D; Blum Murphy M; Shanbhag N; Tatlonghari G; Thomas I; Rogers J; Kobayashi M; Vykoukal J; Estrella JS; Roy-Chowdhuri S; Han G; Zhang S; Mao X; Song X; Zhang J; Gu J; Johnson RL; Calin GA; Peng G; Lee JS; Hanash SM; Futreal A; Wang Z; Wang L; Ajani JA
Gut; 2020 Jan; 69(1):18-31. PubMed ID: 31171626
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral heterogeneity and loss of ARID1A expression in gastric cancer correlates with increased PD-L1 expression in Western patients.
Tober JM; Halske C; Behrens HM; Krüger S; Röcken C
Hum Pathol; 2019 Dec; 94():98-109. PubMed ID: 31704366
[TBL] [Abstract][Full Text] [Related]
19. Association of KMT2C/D loss-of-function variants with response to immune checkpoint blockades in colorectal cancer.
Liu R; Niu Y; Liu C; Zhang X; Zhang J; Shi M; Zou W; Gu B; Zhu H; Wang D; Yuan H; Li W; Zhao D; Zheng Q; Liu R; Chen W; Ma T; Zhang Y
Cancer Sci; 2023 Apr; 114(4):1229-1239. PubMed ID: 36601880
[TBL] [Abstract][Full Text] [Related]
20. Recombinant Human Adenovirus Type 5 (H101) Intra-Tumor Therapy in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer: Genomic Profiling Relating to Clinical Efficacy.
Zhang Q; Zhang J; Liu Z; Wang J; Wang F; Wang T; Shi F; Su J; Zhao Y
Drug Des Devel Ther; 2023; 17():3507-3522. PubMed ID: 38046281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
